WO2004056264A1 - Affichage graphique pour dispositifs medicaux - Google Patents
Affichage graphique pour dispositifs medicaux Download PDFInfo
- Publication number
- WO2004056264A1 WO2004056264A1 PCT/DK2003/000912 DK0300912W WO2004056264A1 WO 2004056264 A1 WO2004056264 A1 WO 2004056264A1 DK 0300912 W DK0300912 W DK 0300912W WO 2004056264 A1 WO2004056264 A1 WO 2004056264A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- display
- blood glucose
- future
- past
- cbgm
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 48
- 239000008103 glucose Substances 0.000 claims abstract description 48
- 239000008280 blood Substances 0.000 claims abstract description 40
- 210000004369 blood Anatomy 0.000 claims abstract description 40
- 238000012806 monitoring device Methods 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 5
- 230000000007 visual effect Effects 0.000 claims 4
- 238000012544 monitoring process Methods 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000004397 blinking Effects 0.000 abstract 1
- 239000003086 colorant Substances 0.000 abstract 1
- 229960001031 glucose Drugs 0.000 abstract 1
- 235000001727 glucose Nutrition 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 4
- 230000000149 penetrating effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
Definitions
- Figure 1c shows that the level has been relatively stable at a high level within the last hour.
- the concentration is increasing and above the critical level, so the color is red.
- Figure 1e shows the opposite situation depicted in Figure 1d.
- Figures 3a-3f illustrate a different embodiment, where the present time is displayed numeri- cally and the blood glucose level, or other parameter of interest, is displayed graphically. This display also shows other information such as battery power, indicated on the right side of the display.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003287925A AU2003287925A1 (en) | 2002-12-19 | 2003-12-19 | Graphical display for medical devices |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43455902P | 2002-12-19 | 2002-12-19 | |
US60/434,559 | 2002-12-19 | ||
DKPA200300154 | 2003-02-04 | ||
DKPA200300154 | 2003-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004056264A1 true WO2004056264A1 (fr) | 2004-07-08 |
Family
ID=32683723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2003/000912 WO2004056264A1 (fr) | 2002-12-19 | 2003-12-19 | Affichage graphique pour dispositifs medicaux |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003287925A1 (fr) |
WO (1) | WO2004056264A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD611151S1 (en) | 2008-06-10 | 2010-03-02 | Lifescan Scotland, Ltd. | Test meter |
USD612274S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland, Ltd. | User interface in an analyte meter |
US8917184B2 (en) | 2008-03-21 | 2014-12-23 | Lifescan Scotland Limited | Analyte testing method and system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
WO2000018293A1 (fr) * | 1997-01-10 | 2000-04-06 | Health Hero Network, Inc. | Systeme de traitement du diabete et methode de controle de la glycemie |
WO2003057027A2 (fr) * | 2001-12-27 | 2003-07-17 | Medtronic Minimed, Inc. | Systeme de controle de caracteristiques physiologiques |
-
2003
- 2003-12-19 AU AU2003287925A patent/AU2003287925A1/en not_active Abandoned
- 2003-12-19 WO PCT/DK2003/000912 patent/WO2004056264A1/fr not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
WO2000018293A1 (fr) * | 1997-01-10 | 2000-04-06 | Health Hero Network, Inc. | Systeme de traitement du diabete et methode de controle de la glycemie |
WO2003057027A2 (fr) * | 2001-12-27 | 2003-07-17 | Medtronic Minimed, Inc. | Systeme de controle de caracteristiques physiologiques |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD612274S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland, Ltd. | User interface in an analyte meter |
US8917184B2 (en) | 2008-03-21 | 2014-12-23 | Lifescan Scotland Limited | Analyte testing method and system |
US9626480B2 (en) | 2008-03-21 | 2017-04-18 | Lifescan Scotland Limited | Analyte testing method and system |
USD611151S1 (en) | 2008-06-10 | 2010-03-02 | Lifescan Scotland, Ltd. | Test meter |
Also Published As
Publication number | Publication date |
---|---|
AU2003287925A1 (en) | 2004-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040153257A1 (en) | Graphical display for medical devices and methods for displaying medical information | |
US8577433B2 (en) | Medical device alarm modeling | |
JP5594935B2 (ja) | 生理的特徴のモニタリングのためのシステム | |
US8279226B2 (en) | Visualization of a parameter which is measured on the human body | |
EP1703839B1 (fr) | Systeme permettant de controler des caracteristiques physiologiques | |
US5417222A (en) | Patient monitoring system | |
US8704666B2 (en) | Medical device interface customization systems and methods | |
EP2471456A1 (fr) | Système de contrôle de caractéristiques physiologiques | |
JP7357707B2 (ja) | ベッドシステム | |
KR20160023807A (ko) | 포도당 측정 시스템 및 아이콘을 표시하는 방법 | |
US20220248988A1 (en) | Digital and user interfaces for analyte monitoring systems | |
CN105451639A (zh) | 用于显示暂时血氧水平的界面 | |
CN113164075B (zh) | 一种监护设备的报警限值设置方法及装置 | |
EP3179901B1 (fr) | Lecteur de glycémie à interface utilisateur peu coûteuse comprenant des indicateurs graphiques programmés | |
US12016683B2 (en) | Portable device, method and medical system for processing continuous monitoring data indicative of an analyte in a bodily fluid | |
WO2004056264A1 (fr) | Affichage graphique pour dispositifs medicaux | |
WO2020133429A1 (fr) | Procédé de surveillance, moniteur et support de stockage informatique | |
WO2020258333A1 (fr) | Procédé et dispositif de surveillance et de traitement et support de stockage | |
WO2014008342A1 (fr) | Dispositif d'affichage d'informations d'analyte de patient | |
CN118201549A (zh) | 用于显示生理传感器的阻抗信息的系统和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |